Literature DB >> 8233079

Propentofylline (HWA285) inhibits the release of dopamine during transient ischemia and modulates its metabolism in rat striatum.

K Shimizu1, M Ogino, N Yamaguchi, S Mitani, R Saito, T Kawase, S Toya.   

Abstract

Propentofylline (HWA285) has been reported to protect neuronal cells through the inhibition of glutamate release during transient ischemia. We studied whether HWA285 inhibits dopamine (DA) release, and how HWA285 modulates DA metabolism in the rat model. HWA285 was perfused through a microdialysis probe placed in the rat striatum during 20 min transient ischemia. In rats perfused by HWA285, ischemic DA release was significantly inhibited, and DA metabolism showed better recovery in contrast with unperfused rats.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8233079     DOI: 10.1016/0304-3940(93)90599-g

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  1 in total

1.  Propentofylline Prevents Sickness Behavior and Depressive-Like Behavior Induced by Lipopolysaccharide in Rats via Neuroinflammatory Pathway.

Authors:  Márcia M T Moraes; Marcella C Galvão; Danilo Cabral; Cideli P Coelho; Nicolle Queiroz-Hazarbassanov; Maria F M Martins; Eduardo F Bondan; Maria M Bernardi; Thiago Berti Kirsten
Journal:  PLoS One       Date:  2017-01-05       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.